Selective Estrogen Receptor Modulator-Associated Nonalcoholic Fatty Liver Disease Improved Survival in Patients With Breast Cancer: A Retrospective Cohort Analysis

Selective estrogen receptor modulator (SERM)-associated nonalcoholic fatty liver disease (NAFLD) might be related to treatment efficacy in patients with breast cancer because of circulating estrogen antagonism. The aim of the study was to investigate the relationship between NAFLD and survival outco...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore)
Main Authors: Zheng, Qiufan, Xu, Fei, Nie, Man, Xia, Wen, Qin, Tao, Qin, Ge, An, Xin, Xue, Cong, Peng, Roujun, Yuan, Zhongyu, Shi, Yanxia, Wang, Shusen
Format: Artigo
Language:Inglês
Published: Wolters Kluwer Health 2015
Subjects:
5700
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616748/
https://ncbi.nlm.nih.gov/pubmed/26448028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001718
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items